We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Draeger Medical to Acquire Neonatal Care Business

By HospiMedica staff writers
Posted on 07 Oct 2003
Print article
In a move to gain access to the US neonatal business, Draeger Medical AG (Luebeck, Germany) has agreed to acquire the Air-Shields infant care business of Hill-Rom Company, a subsidiary of Hillenbrand Industries (Batesville, IN, USA). No financial terms were disclosed.

Air-Shields is an important provider of incubators, infant-warming therapy, and other neonatal products. The company had revenues of about US$40 million in 2002. Draeger plans to consolidate Air-Shields' employees and assets into the Luebeck-based company, giving Draeger access to the US neonatal business.

"We will also be able to offer our North American customers comprehensive solutions combined with patient monitoring,” said Dr. Wolfgang Reim, president and CEO of Draeger Medical. "Clinical staff will benefit from these integrated solutions through increased quality of therapy and process cost reductions.”





Related Links:
Draeger
Hillenbrand
Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Baby Scale
seca 374
New
LED Phototherapy System
neoBLUE compact

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.